Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targetsAgnieszka K. Witkiewicz, Erik S. Knudsen|Nature Communications|2015Cited by 1.1k
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibitionKeelan Z. Guiley, Seth M. Rubin, Tilini U. Wijeratne et al.|Science|2019Cited by 238
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic CancerVishnu Kumarasamy, Agnieszka K. Witkiewicz|Cancer Research|2024Cited by 45
Baseline cell cycle and immune profiles indicate CDK4/6 inhibitor response in metastatic HR + /HER2- breast cancerStephanie L. Tzetzo, Agnieszka K. Witkiewicz|npj Breast Cancer|2025Cited by 4
RB loss sensitizes triple-negative breast cancer to apoptosis induced by cellular stressAgnieszka K. Witkiewicz, Vishnu Kumarasamy|Cell Death Discovery|2025Cited by 2